Cosmos Health vs Prenetics Global
COSM and PRE side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COSM and PRE compare
Prenetics Global grew revenue faster over the last twelve months (480% versus 33.8% for Cosmos Health).
Cosmos Health keeps more of each dollar of sales as profit, with a net margin of −33.1% compared with −40.8% at Prenetics Global.
Prenetics Global scores higher on the StockData Score (10 against 5 for Cosmos Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COSM | PRE |
|---|---|---|
| Size and price | ||
| Market cap | $24.2M | – |
| Share price | $0.240 | $16.72 |
| Change, 1 year | −67.1% | 29.3% |
| Change, 5 years | −93.5% | −88.7% |
| Beta (5Y) | – | 0.60 |
| Employees | 163 | 98 |
| StockData Score | ||
| Total score | 5 | 10 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 0 | 3 (better) |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× | – |
| P/B | 1.2× | – |
| FCF yield | −41.1% | – |
| Fair value | $0.209 | – |
| Margin of safety | −14.8% | – |
| Growth | ||
| Revenue growth (TTM) | 33.8% | 480% (better) |
| Revenue growth, 5Y average | 3.3% | 7.2% (better) |
| Profitability | ||
| Gross margin | 10.3% | 52.8% (better) |
| Operating margin | −24.9% (better) | −48.1% |
| Net margin | −33.1% (better) | −40.8% |
| FCF margin | −13.5% (better) | −23.8% |
| Return on equity | −104% | −23.1% (better) |
| Return on invested capital | −60.9% | −29.0% (better) |
| Financial health | ||
| Debt / equity | 0.06 (better) | 0.00 |
| Interest coverage | −7.8× | – |
| Current ratio | 1.05 | 2.97 (better) |
| Altman Z-score | −2.63 | – |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Buyback yield | −34.6% | – |
| Shareholder yield | −34.6% | – |
| Ownership | ||
| Held by institutions | 2.1% | – |
| Held by insiders | 17.4% | 14.2% |
| Insider net buying, 12 months | $1.6M (better) | $1000K |
| Short interest, % of float | 2.1% | – |
Go deeper
- COSM stock overview
- COSM income statement
- COSM valuation and score
- PRE stock overview
- PRE income statement
- PRE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.